Patent Ductus Arteriosus — Patent Landscape
2
Approved drugs
20
Active US patents
63/100
Avg vulnerability
—
Annual revenue covered
Originators in Patent Ductus Arteriosus
Cliff calendar — next 15 years
8
29
8
30
4
32
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Advil
ibuprofen
|
Generic (originally Boots Group) | 14 | 70 | — | 2029-09-30 |
|
Indocin Sr
INDOMETHACIN
|
— | 6 | 56 | — | 2030-04-23 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 11806400 | Advil | method of use | 76 | 2032-03-16 |
| 11806400 | Advil | method of use | 76 | 2032-03-16 |
| 8871810 | Advil | method of use | 73 | 2029-09-30 |
| 8735452 | Advil | method of use | 73 | 2029-09-30 |
| 9649284 | Advil | method of use | 68 | 2029-09-30 |
| 9295639 | Advil | method of use | 68 | 2029-09-30 |
| 8735452 | Advil | method of use | 68 | 2029-09-30 |
| 9138404 | Advil | method of use | 68 | 2029-09-30 |
| 9114068 | Advil | method of use | 68 | 2029-09-30 |
| 8871810 | Advil | method of use | 68 | 2029-09-30 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 8992982 | Indocin Sr | formulation | 48 | 2030-04-23 |
| 8992982 | Indocin Sr | formulation | 48 | 2030-04-23 |
| 8734847 | Indocin Sr | formulation | 53 | 2030-04-23 |
| 8734847 | Indocin Sr | formulation | 53 | 2030-04-23 |
| 9072661 | Advil | method of use | 68 | 2032-03-16 |
| 9072710 | Advil | method of use | 68 | 2032-03-16 |
| 9012508 | Advil | method of use | 68 | 2030-09-14 |
| 9012508 | Advil | method of use | 68 | 2030-09-14 |
| 9089471 | Indocin Sr | method of use | 68 | 2030-04-23 |
| 9089471 | Indocin Sr | method of use | 68 | 2030-04-23 |
Related
- Patent Ductus Arteriosus — full disease profile
- AI Patent Landscape Report — type "patent ductus arteriosus" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner